Wide Ranks

CPHI

China Pharma Holdings, Inc.

0.2000

Top Statistics
Market Cap 3 M Forward PE 0.0000 Revenue Growth -15.80 %
Current Ratio 0.84 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -70.48 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -4.94 Enterprise / Revenue 1.07 Price To Sales Trailing12 Months 0.6163
Profitability
Profit Margins -70.48 % Operating Margins -150.44 %
Balance Sheet
Total Cash 739337 Total Cash Per Share 0.0430 Total Debt 4 M
Total Debt To Equity 54.77 Current Ratio 0.84 Book Value Per Share 0.7020
All Measures
Short Ratio 22.00 % Message Board Id finmb_24403297 Fax 86 89 8668 19024
Shares Short Prior Month 10115 Return On Equity -0.7489 City Haikou
Uuid 9f146745-b1ca-36b0-bdc6-b6c2de85b2b8 Previous Close 0.1965 First Trade Date Epoch Utc 1 B
Book Value 0.7020 Beta 0.7110 Total Debt 4 M
Volume 81303 Price To Book 0.2849 Last Split Date 1 B
Fifty Two Week Low 0.1700 Total Cash Per Share 0.0430 Total Revenue 6 M
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -150.44 % Net Income To Common -4403835 Ask 0.1990
Short Percent Of Float 0.0122 Implied Shares Outstanding 15 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 232470 Average Volume10days 232470
Total Cash 739337 Next Fiscal Year End 1 B Revenue Per Share 0.6300
Held Percent Insiders 0.5128 Ebitda Margins -21.67 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.1965
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.2290
Open 0.1965 Free Cashflow 669601 Dividend Yield 0.00 %
Return On Assets -0.1754 Time Zone Short Name EST Trailing Eps -0.6900
Day Low 0.1929 Address1 No. 17, Jinpan Road Shares Outstanding 19 M
Price Hint 4 Target High Price 0.0000 Website https://www.chinapharmaholdings.com
52 Week Change -0.6364 Average Volume 407254 Recommendation Key none
Forward Eps 0.0000 Compensation As Of Epoch Date 1 B Quick Ratio 21.70 %
Last Split Factor 1:5 Regular Market Day High 0.2000 Is_sp_500 False
Profit Margins -70.48 % Debt To Equity 54.77 Fifty Two Week High 0.7500
Day High 0.2000 Shares Short 93597 Regular Market Open 0.1965
Industry Key drug-manufacturers-specialty-generic Bid 0.1999 Earnings Growth 0.00 %
Enterprise To Revenue 1.07 Revenue Growth -15.80 % Shares Percent Shares Out 0.0088
Operating Cashflow 327079 Currency USD Time Zone Full Name America/New_York
Market Cap 3 M Is_nasdaq_100 False Zip 570216
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Long Name China Pharma Holdings, Inc.
Regular Market Day Low 0.1929 Held Percent Institutions 0.0021 Current Price 0.2000
Address2 Second Floor Enterprise To Ebitda -4.94 Financial Currency USD
Current Ratio 0.84 Gross Margins -25.89 % Industry Disp Drug Manufacturers - Specialty & Generic
Country China Float Shares 7 M Two Hundred Day Average 0.2772
Enterprise Value 6 M Price To Sales Trailing12 Months 0.6163 Forward PE 0.0000
Regular Market Volume 81303 Ebitda -1353627 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China.

The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension.

In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets.

Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases.

Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks.

It offers its products through distributors, its network of sales offices, and sales representatives.

The company is based in Haikou, the People's Republic of China.